## IONQ: IonQ, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -1.5% below STRENGTH zone (3.0-6.0%); PEG 2.71 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($39.25)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Where Will IonQ Stock Be in 1 Year?**
- Source: Finviz | 20260101T190500 | Somewhat-Bearish | Relevance: 100%
- IonQ, a quantum computing company, experienced significant technical and financial breakthroughs in 2025, with increasing revenues. However, the company faces mounting losses and trades at a high valuation, despite recent dips in share price. While considered a high-risk, high-reward investment, its short-term performance is uncertain, with potential for long-term success if quantum computing proves to be a major technological advancement.

**2. IonQ stock steadies after South Korea 100-qubit Tempo deal as traders eye $45 level**
- Source: ts2.tech | 20251231T020927 | Somewhat-Bullish | Relevance: 100%
- IonQ shares showed minimal movement after closing, following the announcement of a deal to deliver a 100-qubit Tempo quantum system to South Korea’s KISTI. The stock experienced volatility due to year-end profit-taking and thin holiday liquidity, highlighting the company's efforts to convert research into revenue. Traders are now watching the $45 support level and the $47 resistance zone as the year concludes.

**3. Yarbrough Capital LLC Has $1.78 Million Stake in IonQ, Inc. $IONQ**
- Source: MarketBeat | 20260101T140909 | Neutral | Relevance: 100%
- Yarbrough Capital LLC increased its stake in IonQ, Inc. (NYSE:IONQ) by 73.6% in Q3, now holding 28,992 shares valued at $1.78 million. While the company's revenue jumped 221.5% year-over-year to $39.9 million, it reported a significant EPS miss and remains unprofitable, with insiders selling shares worth nearly $6 million. Analyst ratings are mixed, with a consensus "Hold" and a target price of $72.08.

**4. IonQ’s Quantum Bet: Volatile Stock, Big Promises and a Market Struggling to Price the Future**
- Source: AD HOC NEWS | 20260101T020847 | Neutral | Relevance: 100%
- IonQ's stock faces significant volatility, reflecting the high potential but uncertain future of quantum computing. Over the past year, the stock has shown a modest performance despite ambitious growth projections. Analysts maintain a "cautiously constructive" stance, with both "Buy" and "Hold" ratings, as the market weighs IonQ's technological advancements against its commercialization timelines and current revenue base.

**5. Pure Financial Advisors LLC Invests $902,000 in IonQ, Inc. $IONQ**
- Source: MarketBeat | 20251231T110847 | Neutral | Relevance: 100%
- Pure Financial Advisors LLC has acquired a new stake of 14,672 shares in IonQ, Inc., valued at approximately $902,000, bringing institutional ownership in IonQ to about 41.4%. Insider activity shows CRO Rima Alameddine sold 100,000 shares for $4.69 million, while Director William J. Teuber, Jr. bought 2,000 shares for $109,620. Despite a 221.5% revenue jump in Q3, EPS missed estimates, and analysts currently rate the stock as a "Hold" with an average price target of $72.08.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.11M) |
| Sells | 7 ($7.62M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 8.3% (+18.5%)
- Morgan Stanley: 7.4% (+29.9%)
- Blackrock Inc.: 6.3% (+23.2%)
- Geode Capital Manage: 1.9% (+24.0%)
- State Street Corpora: 1.8% (+19.9%)

### Key Risks

1. High beta (2.62) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Insider selling cluster: $7.6M in recent transactions.
3. High short interest (20.2%, 3.5 days to cover): squeeze risk or crowded bearish bet.
4. Near-term weakness: 8.9% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.71 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (8.7x). Revenue growth strong at 82% YoY. Insider selling cluster ($7.6M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.6B |
| Beta | 2.62 |
| 52W Range | $17.88 - $84.64 |
| Short Interest | 20.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.71 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 strengthening from -7.0% to -1.5% (+5.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). MRS_5 turning positive (3.2%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.05x) but short-term weakness (below SMA20). RSI neutral at 46. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.54% (CS: 17) | Neutral |
| RSI_14 | 45.8 | Neutral |
| MACD Histogram | -0.23 | Bearish |
| vs SMA20 | 0.944x | Below |
| vs SMA50 | 0.911x | Below |
| vs SMA200 | 1.047x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $46.77
- **Stop Loss:** $39.25 (16.1% risk)
- **Target:** $54.29 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 159
- **Position Value:** $7,436.43
- **Portfolio %:** 7.44%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-25 (Est: $-0.48)

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*